Immunoblot Method To Detect Streptococcus and Identify Multiple Serotypes from Nasopharyngeal Secretions

Conventional culture techniques are limited in the ability to detect multiple Streptococcus pneumoniae serotypes in nasopharyngeal (NP) secretions. We developed an immunoblot (IB) method with monoclonal antibodies (MAbs) to detect S . pneumoniae and to identify serotypes. NP specimens stored in skim milk-tryptone-glucose-glycerol medium were assessed by the IB method and the reference culture method (RM). In the RM, four optochin-sensitive alpha-hemolytic colonies resembling pneumococci were typed by the Quellung reaction. In the IB method, a nitrocellulose membrane blot of surface growth was reacted with a pneumococcal surface adhesion (PsaA) MAb and visualized. Of 47 NP specimens, 32 (68%) were found to be positive and 13 (28%) were found to be negative for pneumococci by both methods; each method alone yielded one positive result. The sensitivity and specificity of the IB method for the detection of pneumococci were 97 and 93%, respectively. To identify serotypes, blots were tested with serotype-specific MAbs (4, 6A, 6B, 9V, 14, 18C, 19F, and 23F). To detect the remaining serotypes, positive serotype-specific replicate blots were compared visually to an original anti-PsaA-positive blot; four unidentified colonies were subcultured and serotyped by the Quellung reaction. Fifty-eight S. pneumoniae -positive NP specimens containing 69 pneumococcal strains (23 serotypes) were tested; 68 (98.6%) of the strains were detected by the IB method, and 66 (95.6%) were detected by the RM. For 11 specimens found to contain two serotypes, both methods detected both serotypes in 7 (63.6%), the IB method alone detected the two serotypes in 3 (27.3%), and the RM alone detected both serotypes in 1 (9%). The IB method identified multiple clones and minor populations of pneumococci in NP secretions. This method is useful for detecting specific serotypes and carriage of multiple serotypes in epidemiologic surveillance and carriage studies. individually to a BAP with an optochin disk (Taxo P; Becton Dickinson) and incubated. Subcultures with a positive optochin zone of inhibition ( (cid:4) 13 mm) were serotyped by the Quellung reaction. Subcultures with an intermediate zone of inhibition (9 to 13 mm) were confirmed to be S. pneumoniae by a positive bile solubility test and then serotyped as described above (20). The maximum number of CFU that can be screened by this method is four, and the maximum number of serotypes that can be identified by this method is four, unless additional CFU are subcultured and serotyped. The RM results were used to select specimens for this study of the IB method. Thus, specimens were subjected to the RM on two occasions, once as a means of selecting specimens for study and again, several months later, during the course of the comparison study.

[1]  E. Lewis,et al.  Impact of the pneumococcal conjugate vaccine on otitis media , 2003, The Pediatric infectious disease journal.

[2]  E. Lewis,et al.  Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia , 2002, The Pediatric infectious disease journal.

[3]  S. Black,et al.  Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine , 2001, The Pediatric infectious disease journal.

[4]  A. Takala,et al.  Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old. , 2001, The Journal of infectious diseases.

[5]  George M. Carlone,et al.  Evaluation of a Medium (STGG) for Transport and Optimal Recovery of Streptococcus pneumoniae from Nasopharyngeal Secretions Collected during Field Studies , 2001, Journal of Clinical Microbiology.

[6]  S. Lockhart,et al.  Efficacy of a pneumococcal conjugate vaccine against acute otitis media. , 2001, The New England journal of medicine.

[7]  R. Dagan,et al.  LACK OF UTILITY OF SEROTYPING MULTIPLE COLONIES FOR DETECTION OF SIMULTANEOUS NASOPHARYNGEAL CARRIAGE OF DIFFERENT PNEUMOCOCCAL SEROTYPES , 2000, The Pediatric infectious disease journal.

[8]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[9]  R. Huebner,et al.  Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. , 1999, The Journal of infectious diseases.

[10]  E. Shapiro,et al.  Pneumococcal vaccines: history, current status, and future directions. , 1999, The American journal of medicine.

[11]  S. Johnson,et al.  Immunoreactivity of Five Monoclonal Antibodies against the 37-Kilodalton Common Cell Wall Protein (PsaA) ofStreptococcus pneumoniae , 1998, Clinical Diagnostic Laboratory Immunology.

[12]  A. Schuchat,et al.  Bacterial Meningitis in the United States in 1995 , 1997 .

[13]  I. Jado,et al.  Dot blot assay for the serotyping of pneumococci , 1997, Journal of clinical microbiology.

[14]  P. Kolenbrander,et al.  Nucleotide sequence of the Streptococcus gordonii PK488 coaggregation adhesin gene, scaA, and ATP-binding cassette , 1994, Infection and immunity.

[15]  J. Gruber Bacterial meningitis in the United States, 1978 through 1981: The national bacterial meningitis surveillance study , 1985 .

[16]  B. Gray,et al.  Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. , 1980, The Journal of infectious diseases.

[17]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[18]  G. Siber,et al.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  A. Tomasz Streptococcus pneumoniae : molecular biology & mechanisms of disease , 2000 .

[20]  B. Greenwood,et al.  Evaluation of vaccines for the prevention of pneumonia in children in developing countries. , 1999, Epidemiologic reviews.

[21]  D. L. Klein Pneumococcal disease and the role of conjugate vaccines. , 1999, Microbial drug resistance.

[22]  J. Butler Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. , 1997, Microbial drug resistance.